Pedro Perez: Has Computer-Assisted Thrombectomy Actually Improved Patient Care, Or Simply Improved the Tools?
Pedro Perez, Vascular Consultant – PERT and VTE Program Builder at Argon Medical Devices, Inc., shared on LinkedIn:
”Today, we’re entering another shift with Computer Assisted Vacuum Thrombectomy (CAVT) and technologies capable of tissue identification – allowing physicians to distinguish between circulating blood and organized thrombus.
Companies are pushing this tech forward, building on the early work pioneered by physicians.
But the bigger question is this:
Has computer-assisted thrombectomy actually improved patient care… or simply improved the tools?
If these technologies truly deliver greater procedural efficiency, reduced blood loss, and more precise clot removal, then we may be witnessing the next meaningful evolution in VTE treatment.
Curious to hear from others in the field – Are we seeing better outcomes, or just better technology?”
Stay updated with Hemostasis Today.
-
Jul 6, 2026, 19:25Ambreen Kashif: Highlighting the Impact of Temporary Donor Deferrals on Donor Retention
-
Jul 6, 2026, 19:23Rob Mac Sweeney: Anticoagulation Strategies for Cardiopulmonary Bypass in Heparin-Induced Thrombocytopenia
-
Jul 6, 2026, 19:22Nthabiseng Bapela: Interpreting INR in Patients on Warfarin – A Practical Clinical Framework
-
Jul 6, 2026, 19:20Hamza Mohamed: Key Highlights from the 2026 AHA/ACC Multisociety Guideline on Acute PE
-
Jul 6, 2026, 18:58Mostafa Faisal: High PNH Type II Neutrophil Proportions Are Associated With Thrombosis
-
Jul 6, 2026, 17:57When Hematocrit Exceeds 70 Percent: Challenges in Peripheral Blood Smear Evaluation and CBC Analysis – Seema Dawood
-
Jul 6, 2026, 17:382026 ACC/AHA Multisociety Dyslipidemia Guideline: Key Updates for Vascular Specialists – Batool Abuhalimeh
-
Jul 6, 2026, 17:27Nicolas Gendron: Should Carbon Footprint Influence Therapeutic Decisions?
-
Jul 6, 2026, 17:15Sanchit Sharma։ Continuous Anticoagulation in PVT with Varices